Inventor
SIMEON BOWERS
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
C07DHeterocyclic compounds28%
A61KPreparations for medical, dental or toiletry purposes22%
C07BGeneral methods of organic chemistry11%
C07CAcyclic or carbocyclic compounds11%
PatentTitleYear
12,115,154Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9)202411,945,782Composition and methods of use of tetrahydroisoquinoline small molecules to bind and modulate PCSK9 protein activity202411,944,619Phenylalanine small organic compounds to directly modulate PCSK9 protein activity202411,925,637Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use202411,891,369Compounds for binding proprotein convertase subtilisin/kexin type 92024Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2024Patents assigned to SRX CARDIO LLC (5)· patent assignee history
2024Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SRX CARDIO LLC | 5 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2024 |